Here are three observations.
1. In 2017, the market was worth $2.1 billion.
2. The spinal biologics market is anticipated to hit $2.74 billion by 2023.
3. Key market players include NuVasive, X-Spine Systems, Medtronic, Exactech, Arthrex, Zimmer Biomet, Stryker, Orthofix, Wright Medical Technology, DR PRP USA, Nutech, K2M and DePuy Synthes.
More articles on biologics:
6 things to know about Bone Biologics
Dr. Luga Podesta on stem cells in orthopedics, ‘a new frontier in medicine’
Who are the 15 major players in the global orthobiologics market?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.